US00847X1046
US00847X1046
Agios Pharmaceuticals, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 54.028.000 | 36.498.000 | 48.0% |
| Cost of Revenue | 6.345.000 | 4.165.000 | 52.3% |
| Gross Profit | 47.683.000 | 32.333.000 | 47.5% |
| 519.815.000 | 458.070.000 | 13.5% | |
| Operating Income | -472.132.000 | -425.737.000 | 10.9% |
| Pretax Income | -413.797.000 | 717.969.000 | 157.6% |
| Net Income Common Stockholders | -412.781.000 | 673.725.000 | 161.3% |
| -- | -- | -- | |
| -- | -- | -- |